CC vs KRO

For growth investors, The Chemours Company (CC) is the stronger pick with 0.

4% revenue growth year-over-year, versus -1. 5% for Kronos Worldwide, Inc. (KRO). Analysts rate The Chemours Company (CC) a "Hold" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, The Chemours Company (CC) delivered a total return of -19.

1%, compared to -40. 9% for Kronos Worldwide, Inc. (KRO). Over 10 years, the gap is even starker: CC returned +205. 3% versus KRO's +121. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Kronos Worldwide, Inc.

(KRO) is the lower-risk stock at 1. 57β versus The Chemours Company's 1. 92β — meaning CC is approximately 22% more volatile than KRO relative to the S&P 500. On balance sheet safety, Kronos Worldwide, Inc. (KRO) carries a lower debt/equity ratio of 77% versus 18% for The Chemours Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), The Chemours Company (CC) is pulling ahead at 0.

4% versus -1. 5% for Kronos Worldwide, Inc. (KRO). On earnings-per-share growth, the picture is similar: Kronos Worldwide, Inc. grew EPS -228. 0% year-over-year, compared to -549. 1% for The Chemours Company. Over a 3-year CAGR, KRO leads at -1. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Kronos Worldwide, Inc.

(KRO) is the more profitable company, earning -6. 0% net margin versus -6. 6% for The Chemours Company — meaning it keeps -6. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CC leads at -0. 1% versus -1. 7% for KRO. At the gross margin level — before operating expenses — CC leads at 15. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for CC: -6.

5% to $22. 14.

All stocks in this comparison pay dividends.

Kronos Worldwide, Inc. (KRO) offers the highest yield at 2. 6%, versus 2. 2% for The Chemours Company (CC).

For long-horizon retirement investors, Kronos Worldwide, Inc.

(KRO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (2. 6% yield, +121. 1% 10Y return). The Chemours Company (CC) carries a higher beta of 1. 92 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KRO: +121. 1%, CC: +205. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.